Effect of chronic lithium treatment upon the Na-coupIed cotransporters in renal brush border membranes. While the most frequent and prominent side effect of the chrome lithium (Li) administration is dysfunction of collecting ducts and polyuric syndrome, some reports also suggest defects in functions of proximal tubules. We determined the transport properties of brush border membranes (BBM) from kidneys of rats chronically fed for four weeks a chow containing Li (60 mmol/kg; Li-rats) and compared them with BBM from placebo-treated controls. BBM from Li-rats did not differ from controls in Na-
ers in renal brush border membranes. While the most frequent and prominent side effect of the chrome lithium (Li) administration is dysfunction of collecting ducts and polyuric syndrome, some reports also suggest defects in functions of proximal tubules. We determined the transport properties of brush border membranes (BBM) from kidneys of rats chronically fed for four weeks a chow containing Li (60 mmol/kg; Li-rats) and compared them with BBM from placebo-treated controls. BBM from Li-rats did not differ from controls in Nagradient-dependent transport of 32Pi, D-[3H]-glucose or L-[3H1-proline, but showed a considerable increase in the transport rates of ['4C]-citrate (z + 53%; P < 0.001) and ['4C1-succinate ( + 48%, P < 0.005), and also enhanced the rate of Na-H antiport across BBM ( + 30%, P < 0.05). In contrast, direct addition of 1 ms'i Li to BBMV in vitro inhibited Na-dependent transports of both citrate and succinate. The Li-rats had higher plasma level of citrate and decreased ( -50%) renal clearance of citrate. Our results show that chronic exposure to oral Li in vivo results in increased Natgradientdependent transport of polycarboxylic acids and increased Na-H antiport in BBM of proximal tubules; these changes are contrary to effects of Li added to isolated BBM in vitro.
The functional impairments of distal nephron segments, namely vasopressin-resistant decrease in urinary concentrating ability [1, 2] and a mild acidification defect [3] , are the most frequent consequences of chronic oral lithium (Li) administration. However, several observations suggest that Li may also cause pathophysiologic changes in the proximal tubules, a part of the nephron where 80% or more of the filtered Li is reabsorbed [11. The observations pointing to possible effects of Li on the proximal tubules are all based either on studies examining acute or subacute administration of Li in vivo [4] [5] [6] , or on findings of Li effects upon transport in vitro [7-111. Hecht et al [4] observed in a micropuncture study that infusion of Li (plasma Li 2 to 3 mM) was followed by reduced reabsorption of fluid and solutes in the proximal nephron.
Wright et at [8] described that direct addition of Li to isolated rabbit renal brush border membrane vesicles (BBMV) caused inhibition of the Na-gradient-dependent uptake of ['4C]-succinate (Ki = 1.3 mM) and ['4C]-citrate, and to a lesser degree, also
Received for publication August 21, 1992 and in revised form December 14, 1992 Accepted for publication December 15, 1992 © 1993 by the International Society of Nephrology inhibition of BBMV uptake of D-glucose and L-phenylalanine [8] . According to several reports, when added directly in vitro to rabbit BBMV, Li inhibits the amiloride-sensitive Na-H antiport [9-111. According to another report [71, incubation of renal cortical slices in a medium containing Li (0.3 to 2 mM) decreased the uptake of p-amino hippurate (PAH). Subsequent study from the same laboratory has shown that infusion of Li decreases clearance of PAH and the uptake of PAH by renal cortical slices from rats treated four days with Li was blunted [6] . Finally, after a 12 day administration of Li to rats, Bond and Jenner [5] observed increased renal output of a-ketoglutarate and citrate [5] . While results of these studies indeed suggest that Li can alter proximal tubular functions, these experimental conditions are quite remote from chronic oral consumption of relatively small amounts of Li, as it is used in the management of the manic-depressive syndrome.
In view of these considerations, we set out to determine effects of Li under conditions which closely resemble chronic treatment with Li in humans [12, [13] [14] [15] . In this model, Li is administered to rats orally for at least several weeks in solid food simultaneously with ad libitum access to drinking of 0.9% NaCl. This regimen keeps plasma levels of Li in the therapeutic range (< 1 mM Li), prevents intermittent sharp increases in plasma Li and prevents salt depletion which leads to acute Li nephrotoxicity [13, 14, 16] . We examined whether this chronic Li treatment influences one of the key cellular components of transport across proximal tubules: the Na-gradient coupled cotransporters in the luminal brush-border membrane (BBM). The results of our studies document that such chronic treatment with Li selectively alters several Na-cotransporters in renal BBM, and moreover, that these changes are opposite to the in vitro effects of acute Li addition to isolated BBM [8] [9] [10] [11] .
Methods
Experiments were conducted on adult male albino rats of either the Sprague-Dawley or Wistar strains, both purchased from Charles River Breeding Laboratories (Wilmington, Massachusetts, USA). Since results of the studies on these two strains of rats were identical, data are presented interchangeably. The rats were kept in an air conditioned room (21° to 25°C) with a free access to (free choice to drink) both distilled water and a solution of 0.9% NaC1 [2, 12, 13] .
Experimental design As a general rule, rats treated with Li (referred to from here on as Li-rats) and the corresponding controls were always handled and analyzed using paired design 12, 17, 18] . The control and Li-rats entered, completed the treatment regimen, and were sacrificed on the same day, and the blood, urine and kidney cortex were collected and analyzed simultaneously [2, [17] [18] [19] .
Typically, four to six rats, weighing 200 to 230 g, were entered into the protocol as a control group (2 to 3 rats, which received standard chow diets) and as an experimental group (also 2 to 3 rats, which received the same chow but with added Li to the final content of 60 mmol/kg dry weight) [2, 12, 131. The Li containing diet was prepared by adding 1 M LiCl and an approximate amount of water to powdered standard chow to give wet mesh, which was subsequently dried in the oven at 60°C [2] .
Intake of fluids, distilled water and 0.9% NaCI solution was recorded for four days within one week and the body weight once a week. After 24 days, the rats were placed in individual metabolic cages and the urine was collected between 9 a.m. and 12 a.m. [2, 181 . After a total period of 26 to 29 days of the dietary regimen, the rats (control and Li-rats) were anesthetized with intraperitoneal pentobarbital and a sample of blood was taken from the jugular vein. The kidneys were rapidly removed and chilled in ice-cold buffered saline pH 7.4 for preparation of brush-border membrane vesicles (BBMV).
Preparation of BBMV and the transport studies BBMV were prepared from homogenized renal cortical tissue by the slightly modified calcium precipitation procedure described in full in our previous studies on rats [17] [18] [19] [20] . As a final step, the BBMV were washed with 300 m mannitol, 5 mM Tris-Hepes (pH 8.5) and were used immediately for transport studies. Preparation of BBMV, measurements of transport, and determinations of marker enzymes were conducted simultaneously on control and corresponding Li-rats, using the same standards and reagents.
The The rate of Na-H exchange (antiport) was determined by using a rapid filtration technique as described previously [17, 201. When the Na-H exchange across BBMV was measured, BBMV were prepared identical to BBMV for other solute uptake studies [17] [18] [19] [20] [21] , but were preloaded by resuspending and washing the BBMV in an acidic medium containing 150 mM KC1, 25 mri 2-(N-morpholino)-ethanesulphonic acid (MES) and 4.6 mM Tris, adjusted with KOH to pH 6.0 [17, 20] . The rate of Na-H exchange was measured by incubation of BBMV preloaded with acidic intravesicular medium in a medium containing 144 mM KC1, 5 m MES, 13 mM Tris and 13 mM Hepes, adjusted with KOH to pH 7.5 and containing 1 mM 22NaCl (0.2 Ci of 22Na per tube) in a final volume of 45 d.
The incubation was terminated by addition of 3 ml of ice-cold (0 to 2°C) stop solution containing 150 mrvi KC1, 16 mrvi Hepes and 10 mM Tris, adjusted with KOH to pH 7.5 and rapid filtration [14, 17] similar to other transport studies [14] [15] [16] [17] [18] . The 22Na uptake at pH gradient condition (pH1 < pH0) was always measured simultaneously with and without addition of 1 mM amiloride, the maximum inhibitory concentration of the com-
The rate of uptake of all solutes as well as the Na-H exchange rate were expressed in picomoles of solute/mg of BBMV protein per given time interval. In each BBMV preparation, the uptake of solutes was measured in quadruplicate at each time period and the mean SE was entered as N = 1. Protein was measured by the method of Lowry et al [22] after solubilization of the samples in 0.5% sodium dodecyl sulfate, and in our previous studies [17] [18] [19] [20] [21] .
Other analytical methods Activities of BBM marker enzymes, that is, alkaline phosphatase, y-glutamyltransferase and leucine amino-peptidase were assayed by calorimetric methods previously used in studies in this laboratory [17] [18] [19] [20] . All enzyme activities were measured under conditions in which the enzyme reaction rates were linear with respect to incubation time and protein concentrations. There was no difference in the activities of marker enzymes between control and Li-rats, and the BBMV preparations showed the similar enrichment compared to cortical homogenates in both type of rats.
Plasma and urinary citrate were measured enzymatically [21, 23] ; pH, pCO2 and HCO in samples of central venous blood were measured with a blood gas analyzer (Instrumentation Laboratory, Lexington, Massachusetts, USA). Plasma lithium was determined by flame emission spectrophotometry, alter precipitation of proteins with 5% trichloroacetic acid [2] .
The results were evaluated statistically by Student's t-test for groups or paired comparisons as specified in the Results. Values of P> 0.05 were considered not significant (NS).
Results
The model of chronic oral lithium administration of about four weeks duration was designed to approximate pathophysiologic consequences of chronic administration of lithium salts in the clinical setting [2, 22, 23] . Indeed, using this regimen rats developed polyuric syndrome while the plasma levels of Li remained within the range of values (< 1 mM), which are considered within therapeutic range (The term "therapeutic" denotes values considered sale and effective in chronic clinical treatment of manic-depressive syndrome.) ( Table 1) .
The capacity for Na-cotransport of several distinct solutes by BBMV prepared from Li-rats showed specific alterations as compared to controls (Fig. 1) . While the Na-gradient (Na0 > Na1 were markedly (cca + 40 to 60%) enhanced in BBMV from Li rats ( Table 2 , Fig. 1 ). There were no significant differences in uptakes of any of these solutes in the absence of Nat-gradient (NaCl replaced by KC1), and also the uptakes of 32Pi,
-succinate at equilibrium point (120 mm) were not statistically different ( Table 2 ).
The uptake of solutes at the equilibrium point tended to be slightly higher in Li-rats (Table 2) . When the Na-gradient dependent uptake of [14C]-citrate was re-examined in another experimental group (Table 3A) , these results affirmed that in BBMV from Li-rats the Na -dependent concentrative uptake of ['4C]-citrate was markedly increased, whereas at equilibrium time (120 mm) the uptake was not significantly enhanced. The finding of no significant differences in the Na-gradient-dependent uptakes of 32Pi-phosphate, L-[3H}-proline and D-[3H1-glucose between Li-treated and control animals also indicates that the higher rate of uptake of ['4C]-citrate and ['4C]-succinate cannot be accounted for by changed conductance of Na in BBM and the higher efficiency of the (Na0 > Na)-gradient as driving forces in Li-rats ( Table 3A ) after in vitro addition of 1 mrs Li (Table 3B) . Similarly to BBMV from rabbit kidney [8] , direct addition of Li in vitro resulted in the inhibition of both Nat-gradient dependent uptakes of ['4C]-citrate and ['4C]-succinate by rat BBMV (Table 3B) . BBMV from Li-treated rats also showed increased capacity for Na-H antiport (Fig. 1, Table 4 ), determined as 22Na uptake in the presence of outwardly directed (pH1 < pH0) proton gradient and sensitive to inhibition by amiloride [9-11, 17, 19] in the initial phases (0 to 30 sec) of the uptake where the 22Na uptake increased proportionally to elapsed time. However, no significant difference was observed between control BBMV and BBMV from Li-rats in the initial phases (10 to 30 sec) of uptake of 22Na insensitive to amiloride; also, uptake of 22Na uptake at the equilibrium (110 mm) did not differ between BBMV from kidneys of controls and from Li-rats (Table 4A) . Identical results were obtained in another series of experiments (Table 4B ) when the parameters were measured at different initial (15 see) and equilibrium (90 mm) phases. In order to discern whether increased activity of Na-citrate and Natsuccinate contransporters in Li-rats had impact on renal handling of citrate in vivo, we determined, at least approximately, several parameters of renal citrate excretion measured and/or calculated from other values ( Table 1 ). The Li-rats had significantly increased plasma citrate ( + 20%), no significant difference in the total urinary citrate excretion x V), and about -50% lower renal clearance of citrate (Table  1) . On the other hand, plasma creatinine and plasma pH did not differ between Li-rats and controls.
Discussion
The most prominent renal side effects of chronic oral treatment with Li include the well-known polyuric syndrome resistant to vasopressin [1, 2] , the relatively mild distal renal acidification defect [3] , as well as ultrastructural injury in distal segments of tubules [14] . Nevertheless, several observations [4] [5] [6] [7] [8] [9] [10] [11] prompted us to inquire whether the functions of cortical proximal tubules may also be affected due to chronic oral administration of Li. Thus, we examined the effects of chronic exposure of Li on the function of several Na-coupled transporters in the proximal tubular of BBM, which represent rate-limiting steps in the transepithelial proximal reabsorption of several key solutes.
No change in the capacity for NatPi cotransport across BBM corresponded well to the reports which show that administration of Li does not alter the urinary excretion of Pi [24, 25] . Wright et al [8] reported that Li added in low concentrations in vitro to BBMV inhibits Na-dependent cotransport of polycarboxylic acids across rabbit BBM; this led us to also determine the Natcotransports of citrate and succinate in our model.
We confirmed that direct addition of Li in vitro indeed causes inhibition of Na-cotransports of citrate and succinate in the rat BBMV, and hence, is not species-specific (Table 3B ). Direct addition of 1 mt Li to BBMV from normal (control) rats caused marked inhibition of Na-['4C]-citrate uptake ( -40%), and to a lesser degree inhibition of [14C]-succinate (i -17%) uptake; the equilibrium uptakes were not affected (Table 3B) .
However, in contrast to the direct effects of in vitro added Li (Table 3B , [8] ), in BBMV from Li-rats the capacity for Nat gradient dependent uptakes of citrate and succinate were significantly enhanced (Tables 2 and 3A , Fig. 1 ). These alterations were specific, as compared to finding no significant changes in other solute-specific Na1-cotransporters within the same BBMVs (Table 2 ). Similarly, in previous studies [9] [10] [11] direct addition of Li was reported to inhibit Na-H antiport across rabbit BBM. Chronic exposure of BBM to Li in vivo elicited change in the opposite direction: the increase in capacity for Na-H antiport in BBMV from Li-rats (Fig. 1 , Table 4 ). 
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difference did not reach statisticaly significance (Tables 2, 3 and  4) . However, even if the slight increase in intravesicular volume of BBMV from Li-rats could have contributed to higher rate of uptake of solutes in general, the results show (Tables 2, 3A and 4) that increases of Natcitrate and Na-succinate uptakes, as well as the NatH exchange in BBMV from Li-rats, cannot be accounted for solely or predominantly by higher intravesicular volume. (It should be noted that any increase of volume of sphere changes as a cubic function of diameter, whereas the surface changes as a quadratic function of diameter. Therefore, increase in volume has far lesser impact upon the increase of surface, that is, transporting membrane.)
Comparison of our observations (Tables 1 to 3 , Fig. 1 ) with reported effects of Li salts administered in vivo on renal excretion should be briefly considered. Bond and Jenner [5] reported increased total urinary excretion of citrate (the clearances were not measured) after so-called "chronic" administration of Li. However, in their experiments the citrate excretion was measured after only 12 days of LiCl intake, and plasma levels of Li and citrate were not reported [5] . Consequently, their results are not amenable for any meaningful comparison with results of our present studies, which were conducted using a different experimental design. The model of renal changes consequent to chronic Li treatment employed in our study was intentionally developed to approximate, as closely as possible, the situation occurring in clinical chronic treatment of manic-depressive disorders with Li salts [12] [13] [14] [15] . Previous studies documented that functional [13] Table 2 . (Na0 > Nat) gradient-dependent (NaC1 in medium) and Na-independent (KC1 in medium) uptake of solutes by the renal brush border vesicles (BBMV) from control rats and rats subjected to chronic Li treatment (Li-rats) a Number of paired experiments b Significantly different from controls (paired 1-test, P < 0.02) C Relative (percent) increase significant (paired 1-test, P < 0.01); also significantly different from value at 120 mm (group 1-test; P < 0.05) d Not significantly different from controls either by paired or group t-tests and histochemical [14] changes develop fully only after four weeks of Li regimen. However, future time-course studies could determine at which time interval within the four week course of Li administration the observed changes in BBMV Na-cotransporters do develop.
Our findings of increased capacity of Nat-citrate cotransport across proximal tubular BBM in the rat kidney consequent to chronic oral treatment with Li, seems to be reflected in renal parameters of citrate dynamics observed in vivo (Table 1) .
Similarly, as reported previously by Mellerup eta! [26] , chronic administration of Li to rats caused about a 20% increase in plasma citrate. No difference in plasma creatinine suggests no difference in GFR between Li-rats and controls (Table 1) . We thus suggest, very guardedly, that the decreased renal clearance of citrate, which occurred despite an increased filtered load, is likely due to the increased capacity of Na-citrate cotransporter in BBM. As pointed out by Hamm [27] , the proximal luminal uptake of citrate by BBM increases with decreasing pH of luminal fluid. It should thus be considered that lowering the pH of proximal tubular fluid, due to the increased Na-H exchange rate (Table 4) , might be an additional factor favoring (1-test) proximal citrate reabsorption in Li-rats. However, renal handling and metabolism of citrate is very complex [27] , and interpretations surmised here are only hypothetical.
Which biochemical changes of BBM from Li-rats are the basis of the observed functional differences also remain to be determined. In this connection, we would like to point out that Li is a potent inhibitor of myo-inositol-1-phosphatase, one of the key enzymes in the phosphoinositide cycle [281, and it was reported that administration of Li to rats enhances many-fold the content of myo-inositol-1-phosphate content in the kidney [29] . In view of such findings, prolonged inhibition of myoinositol-l-phosphatase might possibly cause an alteration of phosphoinositide metabolism in BBM which might, by a yet unknown mechanism, increase the Na-citrate and Na-succinate cotransporter activities as well as the Na-H antiporter (Fig. 1) . In conclusion, we stress that the model of chronic oral administration of Li to rats was designed [2, 12, 13, 15, 16 ] to closely resemble the therapeutic regimen in the clinical practice and to minimize toxic renal effects of Li. Yet, even in this model we detected specific alterations in the function of Na-cotransporters in proximal tubular BBM without any changes in microscopic cellular morphology [14] . Also, functional external manifestations of these changes in overall renal excretory parameters are certainly less obvious than the dramatic polyuric syndrome due to Li actions on distal nephron [1, 2] .
